Ken Griffin Hookipa Pharma Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Hookipa Pharma Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 16,700 shares of HOOK stock, worth $77,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,700
Previous 25,400
34.25%
Holding current value
$77,989
Previous $18,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding HOOK
# of Institutions
43Shares Held
23.7MCall Options Held
98.5KPut Options Held
46.6K-
Eco R1 Capital, LLC San Francisco, CA5.72MShares$26.7 Million0.12% of portfolio
-
Artal Group S.A. Luxembourg, N45.67MShares$26.5 Million0.21% of portfolio
-
Knoll Capital Management, LLC Miami, FL5.52MShares$25.8 Million2.2% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.12MShares$9.9 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA1.06MShares$4.97 Million0.04% of portfolio
About HOOKIPA Pharma Inc.
- Ticker HOOK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 51,654,500
- Market Cap $241M
- Description
- HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transpl...